Global Pediatric Interventional Cardiology Industry By Devices (Heart Defect Closure Devices, Transcatheter Heart Valves) – Market Forecast and Size Analysis 2019-2025.
Product Code: RP-ID-10078918 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10078918
Market Overview:
Global Pediatric Interventional Cardiology Industry By Devices (Heart Defect Closure Devices, Transcatheter Heart Valves) – Market Forecast and Size Analysis 2019-2025.
Global Pediatric Interventional Cardiology Industry was valued at USD 1606 Million in the year 2017. Global Pediatric Interventional Cardiology Industry is further estimated to grow at a CAGR of 6.7% from 2019 to reach USD 1865 Million by the year 2025. The North America region holds the highest Industry share in 2017 and the Asia Pacific is considered as the fastest growing Industry XX% in the forecasted period. At a country level, US, China and U.S. are projected to grow strongly in the coming years due to increasing density of population.
Major market players in Pediatric Interventional Cardiology Industry are GE Healthcare, Siemens Healthcare, Toshiba Corp., Gore Medical, Medtronic Inc., St. Jude Medical, Abbott Vascular, Boston Scientific Corp., Cordis Corp., Numed Inc., and brief overview of 10 companies is also provided in the report. Rising research and development expenses are catering to changing demand of end users. Similarly, growth strategies such as acquisition, merger and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
SWOT Analysis of Pediatric Cardiology Industry:
Strength:
Rising instances of congenital heart defects
Weakness:
High cost
Opportunities:
Advancement in technology
Threats:
Stringent regulatory procedures
The Global Pediatric Interventional Cardiology Industry is segmented as By Type and Region.
The Devices Industry is further divided into structural heart defect closure devices, transcatheter heart valves, and others. The structural heart defect closure devices segment is sub-divided into atrial septal defect closure devices, ventricular septal defect closure devices, patent foramen ovale, patent ductus arteriosus, and left atrial appendage closure devices. The transcatheter heart valves segment is classified into transcatheter pulmonary valves and transcatheter aortic valves. The Others segment consist of devices such as catheters, guidewires, stents, and balloons.
Pediatric Interventional Cardiology Industry Segmentation:
By Devices
• Heart Defect Closure Devices
• Transcatheter Heart Valves
• Others
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Related Reports
Study Period : 2023-2035
Report Format : PDF,PPT
Delivery Timeline : 48-72 Business Hours
Proof of Quality & Reliability
